HBM BIOVENTURES CAYMAN LTD Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HBM BIOVENTURES CAYMAN LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HBM BIOVENTURES CAYMAN LTD. HBM BIOVENTURES CAYMAN LTD is 10% Owner in MICRUS ENDOVASCULAR CORP ($MEND) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in Aspreva Pharmaceuticals CORP ($ASPV) and 10% Owner in Nabriva Therapeutics AG ($NBRV) and 10% Owner in Nabriva Therapeutics Plc ($NBRV) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL).
Latest Insider Trading Transactions of HBM BIOVENTURES CAYMAN LTD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ASPV, ICGN, MEND, NBRV, NBRV, PRTK, HOWL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | HOWL | Werewolf Therapeut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Option Exercise | C | 0.00 | 5,426,819 | 0 | 0 | |
| May 05 2021 | HOWL | Werewolf Therapeut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Buy | C | 0.00 | 625,995 | 0 | 625,995 | 0 to 626 K |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.52 | 3,429 | 29,224 | 2,334,128 | 2.3 M to 2.3 M (-0.15 %) |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.54 | 22,721 | 193,956 | 2,337,557 | 2.4 M to 2.3 M (-0.96 %) |
| Sep 14 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 8.63 | 10,458 | 90,236 | 2,360,278 | 2.4 M to 2.4 M (-0.44 %) |
| Sep 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 9.50 | 639 | 6,071 | 2,370,735 | 2.4 M to 2.4 M (-0.03 %) |
| Aug 09 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 2,013 | 21,137 | 2,371,374 | 2.4 M to 2.4 M (-0.08 %) |
| Aug 09 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 17,790 | 186,795 | 2,373,387 | 2.4 M to 2.4 M (-0.74 %) |
| Aug 01 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.51 | 6,585 | 69,195 | 2,391,177 | 2.4 M to 2.4 M (-0.27 %) |
| Jul 26 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 160 | 1,680 | 2,397,762 | 2.4 M to 2.4 M (-0.01 %) |
| Jul 24 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 23,445 | 246,173 | 2,397,922 | 2.4 M to 2.4 M (-0.97 %) |
| Jul 24 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 20,786 | 218,253 | 2,421,367 | 2.4 M to 2.4 M (-0.85 %) |
| Jul 21 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 23,445 | 246,173 | 2,397,922 | 2.4 M to 2.4 M (-0.97 %) |
| Jul 21 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 20,786 | 218,253 | 2,421,367 | 2.4 M to 2.4 M (-0.85 %) |
| Jul 18 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 1,339 | 14,060 | 2,442,153 | 2.4 M to 2.4 M (-0.05 %) |
| Jul 18 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 47,460 | 498,415 | 2,443,492 | 2.5 M to 2.4 M (-1.91 %) |
| Jul 18 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.53 | 21,055 | 221,789 | 2,490,952 | 2.5 M to 2.5 M (-0.84 %) |
| Jul 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.54 | 39,914 | 420,757 | 2,512,007 | 2.6 M to 2.5 M (-1.56 %) |
| Jul 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 13,740 | 144,271 | 2,551,921 | 2.6 M to 2.6 M (-0.54 %) |
| Jul 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.52 | 3,521 | 37,027 | 2,565,661 | 2.6 M to 2.6 M (-0.14 %) |
| Jul 07 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.50 | 133 | 1,397 | 2,569,182 | 2.6 M to 2.6 M (-0.01 %) |
| Jul 07 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.52 | 2,562 | 26,960 | 2,569,315 | 2.6 M to 2.6 M (-0.10 %) |
| Jul 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.95 | 11,352 | 124,250 | 2,571,877 | 2.6 M to 2.6 M (-0.44 %) |
| Jul 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.94 | 1,775 | 19,420 | 2,583,229 | 2.6 M to 2.6 M (-0.07 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.72 | 1,603 | 17,189 | 2,585,004 | 2.6 M to 2.6 M (-0.06 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.10 | 4,789 | 53,158 | 2,586,697 | 2.6 M to 2.6 M (-0.18 %) |
| Jun 29 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.83 | 2,166 | 23,457 | 2,591,396 | 2.6 M to 2.6 M (-0.08 %) |
| Jun 05 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.27 | 400 | 4,508 | 2,593,562 | 2.6 M to 2.6 M (-0.02 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.03 | 15,130 | 166,813 | 2,593,962 | 2.6 M to 2.6 M (-0.58 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 100 | 1,100 | 2,609,092 | 2.6 M to 2.6 M (0.00 %) |
| Apr 28 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 709 | 7,799 | 2,609,192 | 2.6 M to 2.6 M (-0.03 %) |
| Apr 25 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.04 | 2,622 | 28,937 | 2,609,901 | 2.6 M to 2.6 M (-0.10 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.00 | 325 | 3,575 | 2,612,523 | 2.6 M to 2.6 M (-0.01 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.07 | 11,785 | 130,434 | 2,612,848 | 2.6 M to 2.6 M (-0.45 %) |
| Apr 20 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.16 | 11,822 | 131,880 | 2,624,633 | 2.6 M to 2.6 M (-0.45 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.13 | 10,984 | 122,232 | 2,636,455 | 2.6 M to 2.6 M (-0.41 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.22 | 13,250 | 148,653 | 2,647,439 | 2.7 M to 2.6 M (-0.50 %) |
| Apr 13 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.40 | 8,597 | 98,034 | 2,660,689 | 2.7 M to 2.7 M (-0.32 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.73 | 37,876 | 406,451 | 185,394 | 223.3 K to 185.4 K (-16.96 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 10.96 | 18,001 | 197,291 | 223,270 | 241.3 K to 223.3 K (-7.46 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.04 | 3,500 | 38,640 | 241,271 | 244.8 K to 241.3 K (-1.43 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.20 | 24,600 | 275,520 | 244,771 | 269.4 K to 244.8 K (-9.13 %) |
| Apr 10 2017 | NBRV | Nabriva Therapeuti ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 11.28 | 6,617 | 74,640 | 269,371 | 276 K to 269.4 K (-2.40 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 30.25 | 3,700 | 111,934 | 1,747,680 | 1.8 M to 1.7 M (-0.21 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 29.52 | 6,300 | 185,973 | 1,751,380 | 1.8 M to 1.8 M (-0.36 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 32.16 | 2,365 | 76,048 | 1,757,680 | 1.8 M to 1.8 M (-0.13 %) |
| Jun 01 2015 | PRTK | Paratek Pharmaceut ... | HBM Healthcare Investments (Ca ... | 10% Owner | Sell | S | 31.52 | 8,215 | 258,937 | 1,760,045 | 1.8 M to 1.8 M (-0.46 %) |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | X | 7.52 | 117,081 | 880,449 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 7.52 | 117,081 | 880,449 | 117,081 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 7.52 | 117,081 | 880,449 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | X | 7.52 | 233,578 | 1,756,507 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | X | 0.00 | 88,384 | 18 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 388,888 | 0 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 467,155 | 0 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 872,040 | 0 | 0 | |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | X | 0.00 | 37,094 | 0 | 1,927,561 | 1.9 M to 1.9 M (+1.96 %) |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | X | 0.00 | 74,002 | 0 | 1,890,467 | 1.8 M to 1.9 M (+4.07 %) |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | X | 0.00 | 88,382 | 0 | 1,816,465 | 1.7 M to 1.8 M (+5.11 %) |
| Jun 23 2005 | MEND | MICRUS ENDOVASCULA ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | C | 0.00 | 1,728,083 | 0 | 1,728,083 | 0 to 1.7 M |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 312,500 | 0 | 0 | |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 166,667 | 0 | 0 | |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Option Exercise | C | 0.00 | 575,000 | 0 | 0 | |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | C | 0.00 | 312,500 | 0 | 1,200,000 | 887.5 K to 1.2 M (+35.21 %) |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | C | 0.00 | 312,500 | 0 | 887,500 | 575 K to 887.5 K (+54.35 %) |
| Feb 10 2005 | ICGN | ICAGEN INC | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | C | 0.00 | 575,000 | 0 | 575,000 | 0 to 575 K |
| Mar 17 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 12.50 | 8,300 | 103,750 | 3,964,615 | 4 M to 4 M (+0.21 %) |
| Mar 17 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 13.00 | 12,000 | 156,000 | 3,956,315 | 3.9 M to 4 M (+0.30 %) |
| Mar 17 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 13.00 | 11,915 | 154,895 | 3,944,315 | 3.9 M to 3.9 M (+0.30 %) |
| Mar 10 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 15.51 | 300,000 | 4,653,000 | 5,367,554 | 5.1 M to 5.4 M (+5.92 %) |
| Mar 10 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 15.55 | 166,000 | 2,581,300 | 5,067,554 | 4.9 M to 5.1 M (+3.39 %) |
| Mar 08 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 15.18 | 306,400 | 4,651,152 | 4,901,554 | 4.6 M to 4.9 M (+6.67 %) |
| Mar 08 2005 | ASPV | Aspreva Pharmaceut ... | HBM BIOVENTURES CAYMAN LTD | 10% Owner | Buy | P | 13.65 | 1,160,000 | 15,834,000 | 4,595,154 | 3.4 M to 4.6 M (+33.77 %) |
Page: 1